VENTURE CAPITAL PARTNERS

Bioindustrial Innovation Canada has signed Memorandums of Understanding (MOUs) with the following organizations.

arctern.jpg

ArcTern Ventures (ATV), is a privately-backed Ontario –based venture capital fund which focuses on early stage investing in companies within cleantech markets. ATV is an established venture capital firm, partnered with the MaRS Discovery District, and has a diversified portfolio of investments across the cleantech sector. Additionally ATV provides advisory services and hands-on management.

BDC_Logo_Horiz_RGB (web).jpg

BDC Capital is the investment arm of BDC, the bank for Canadian entrepreneurs. With over $3 billion under management, BDC Capital serves as a strategic partner to the country’s most innovative firms. It offers businesses a full spectrum of capital, from seed investments to growth equity, supporting Canadian entrepreneurs who have the ambition to stand out on the world stage. Visit bdc.ca/capital.

Cycle_Capital_logo_print_noir.jpg

Cycle Capital is an impact investor and the leading private cleantech venture capital firm with asset of more than $500M. With offices in Montreal, Toronto and Qingdao, mainland China, and a presence in New York and Seattle, Cycle Capital invests in companies developing and commercializing clean technologies and striving to reduce greenhouse gas emissions, optimizing resource use, and improving process efficiency throughout a product’s life cycle. Cycle Capital is the founder of Cycle Momentum – a cleantech accelerator and innovation engine.

Fra.png

FMMC is focused on helping medium sized businesses grow. Each of our partners has over 20 years’ experience in finance and operations related to medium sized Canadian business.

We make direct  investments of $2-$10 million  in cashflowing businesses across most industry sectors through our own funds.  FMMC Buyout Fund focuses on privately owned businesses with enterprise values of $5 to $50 million and our FMMC Private Yield Fund focuses on making subordinated loans to both private and publicly traded companies with EBITDA ranging from $1.5 to about $15 million. 

 

Not sure whether you need equity or debt?  We do both, so can work with you to ensure the best fit for your specific business and owner situation. We also offer a comprehensive suite of Investment Banking and Advisory Services  including mergers and acquisitions and helping boards and shareholders with a variety of other strategic advisory assignments.

GreenSky-Capital.jpg

GreenSky Capital Inc. is an award-winning Toronto-based firm that provides merchant bank and corporate financial advisory services to small and medium sized technology firms within the IT, cleantech and medtech sectors. GreenSky looks for long-term partnerships with high-growth potential companies and dedicated entrepreneurs. GreenSky principals bring a unique combination of experience in technology, law and finance into a real-world context. GreenSky Capital makes investments in early-stage Canadian technology companies through its affiliated venture capital funds, GreenSky Accelerator Fund I, LP and GreenSky Accelerator Fund II, LP.

BIC and GSC have agreed  to work together to exchange information, to establish business relations between their networks, and to develop research and development, demonstration projects, and commercialization for companies that provide clean, green and sustainable technologies. 

Relationships with and between industrial, academic or governmental organizations will be established in order to initiate projects in research and development, demonstration and/or commercial partnering. BIC and GSC will jointly support the initiation of these projects and following due diligence may invest in companies on a collaborative or separate and individual basis. 

Little Green Bamboo Logo.jpg

Based in Vancouver, Canada, Little Green Bamboo (LGB) is a venture fund that aims to support impact and deep-science driven founders. LGB aims to solve the world’s greatest challenges by helping to bridge the chasm between research and commercialization, and providing long-term capital and personalized support. We have an industry focus on material science and life science. 


We have a reputation for being a Silicon Valley “outsider” and for being different from other venture investors. We also aim to nurture an entrepreneurship ecosystem that is different. First, we invested a significant amount of resources to build our internal systems and guidelines based on a comparative analysis we did between the most ethical investors and the worst offenders. Then, we partnered with non-profit, academic, and government institutions, a select handful of for-profit investors who also walk the talk, and select corporations who have shown a commitment to social impact and innovation to help create a virtuous flywheel effect."

Sofinnova.PNG

Sofinnova Partners is an independent venture capital firm based in Paris, France. For more than 40 years, the firm has backed nearly 500 companies at different stages of their development – pure creations, spin-offs, as well as turnaround situations – and worked alongside key entrepreneurs in the Life Sciences industry around the globe. With over €1.6 billion of funds under management, Sofinnova Partners has created market leaders with its experienced team and hands-on approach in building portfolio companies through to exit.